{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:14:01Z","timestamp":1790172841051,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10067-018-4164-5","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T01:37:51Z","timestamp":1528335471000},"page":"2633-2641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-8897","authenticated-orcid":false,"given":"Ali Ismail A.","family":"Al-Gareeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiq Isho","family":"Gorial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"4164_CR1","first-page":"21","volume":"60","author":"VR Joshi","year":"2012","unstructured":"Joshi VR (2012) Rheumatology, past present and future. J Assoc Physicians India 60:21\u201324","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"4164_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2217\/ijr.13.24","volume":"8","author":"F Salaffi","year":"2013","unstructured":"Salaffi F, Ciapetti A (2013) Clinical disease activity assessments in rheumatoid arthritis. Int J Clin Rheumatol 8(3):347\u2013360","journal-title":"Int J Clin Rheumatol"},{"key":"4164_CR3","first-page":"1245","volume":"11","author":"AM Wasserman","year":"2011","unstructured":"Wasserman AM (2011) Diagnosis and Management of rheumatoid arthritis. Am Fam Physician 11:1245\u20131252","journal-title":"Am Fam Physician"},{"key":"4164_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.autrev.2010.04.002","volume":"9","author":"C Papagoras","year":"2010","unstructured":"Papagoras C, Voulgari PV, Drosos AA (2010) Strategies after the failure of the first anti-tumor necrosis factor \u03b1 agent in rheumatoid arthritis. Autoimmun Rev 9:574\u2013582","journal-title":"Autoimmun Rev"},{"key":"4164_CR5","first-page":"35","volume":"9","author":"J Detert","year":"2015","unstructured":"Detert J, Klaus P (2015) Biologic monotherapy in the treatment of rheumatoid arthritis. Biologics 9:35\u201343","journal-title":"Biologics"},{"issue":"1","key":"4164_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233\u2013255","journal-title":"Immunol Rev"},{"key":"4164_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","volume":"19","author":"F Bustamante Marta","year":"2017","unstructured":"Bustamante Marta F, Garcia-Carbonell R, Whisenant Katrijn D, Guma M (2017) Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 19:110","journal-title":"Arthritis Res Ther"},{"key":"4164_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/ard.2006.057497","volume":"66","author":"G Cohen","year":"2007","unstructured":"Cohen G, Gossec L, Dougados M, Cantagrel A, Goupille P, Daures JP, Rincheval N, Combe B (2007) Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann Rheum Dis 66:358\u2013363","journal-title":"Ann Rheum Dis"},{"key":"4164_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","volume":"41","author":"C Wei","year":"2018","unstructured":"Wei C, Mook RA Jr, Premont RT, Wang J (2018) Niclosamide: beyond an antihelminthic drug. Cell Signal 41:89\u201396","journal-title":"Cell Signal"},{"key":"4164_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.intimp.2015.11.002","volume":"31","author":"M Huang","year":"2016","unstructured":"Huang M, Zeng S, Qiu Q, Xiao Y, Shi M, Zou Y, Yang X, Xu H, Liang L (2016) Niclosamide induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes. Int Immunopharmacol 31:45\u201349","journal-title":"Int Immunopharmacol"},{"key":"4164_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","volume":"18","author":"HA Elshabrawy","year":"2015","unstructured":"Elshabrawy HA, Chen Z, Volin MV, Ravella S, Virupannavar S, Shahrara S (2015) The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis 18:433\u2013448","journal-title":"Angiogenesis"},{"key":"4164_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00011-015-0888-8","volume":"64","author":"M Huang","year":"2015","unstructured":"Huang M, Qiu Q, Zeng S, Xiao Y, Shi M, Zou Y, Ye Y, Liang L, Yang X, Xu H (2015) Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells. Inflamm Res 64:1023\u20131032","journal-title":"Inflamm Res"},{"key":"4164_CR13","doi-asserted-by":"crossref","unstructured":"Arnett FC , Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u201324","DOI":"10.1002\/art.1780310302"},{"key":"4164_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12325-016-0371-0","volume":"33","author":"GW Cannon","year":"2016","unstructured":"Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K et al (2016) Clinical outcomes and biologic costs of switching between tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis. Adv Ther 33:1347\u20131359","journal-title":"Adv Ther"},{"key":"4164_CR15","doi-asserted-by":"publisher","first-page":"R347","DOI":"10.1186\/ar1005","volume":"5","author":"RF Vollenhoven Van","year":"2002","unstructured":"Van Vollenhoven RF, Ernestam S, Harju A, Bratt J, Klareskog L (2002) Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious. Arthritis Res Ther 5:R347\u2013R351","journal-title":"Arthritis Res Ther"},{"key":"4164_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/OARRR.S131668","volume":"9","author":"AE Bello","year":"2017","unstructured":"Bello AE, Perkins EL, Jay R, Efthimiou P (2017) Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis. Open Access Rheumatol 9:67\u201379","journal-title":"Open Access Rheumatol"},{"key":"4164_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/ar4428","volume":"16","author":"DT Felson","year":"2014","unstructured":"Felson DT, LaValley MP (2014) The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing. Arthritis Res Ther 16:101","journal-title":"Arthritis Res Ther"},{"key":"4164_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/ard.2006.068304","volume":"66","author":"DE Furst","year":"2007","unstructured":"Furst DE, Gaylis N, Bray V, Olech E, Yocum D, Ritter J, Weisman M, Wallace DJ, Crues J, Khanna D, Eckel G, Yeilding N, Callegari P, Visvanathan S, Rojas J, Hegedus R, George L, Mamun K, Gilmer K, Troum O (2007) Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. Ann Rheum Dis 66:893\u2013899","journal-title":"Ann Rheum Dis"},{"key":"4164_CR19","first-page":"1","volume":"2016","author":"C Yongsong","year":"2016","unstructured":"Yongsong C, Oiling Y, Ke X, Jialin Z, Yuanbo L, Xiaoqing W et al (2016) Assessment of the therapeutic effect of total glucosides of peony for juvenile idiopathic arthritis: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2016:1\u201313","journal-title":"Evid Based Complement Alternat Med"},{"key":"4164_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2018.00040","volume":"5","author":"H Canhao","year":"2018","unstructured":"Canhao H, Rodriguer AM, Gregorio MJ, Dias SS, Comes JA, Santos MJ et al (2018) Common evaluations of disease activity in rheumatoid arthritis reach discordant classifications across different populations. Frontiers in Medicine 5:1\u20138","journal-title":"Frontiers in Medicine"},{"issue":"8","key":"4164_CR21","doi-asserted-by":"publisher","first-page":"e2859","DOI":"10.1097\/MD.0000000000002859","volume":"95","author":"J Feng","year":"2016","unstructured":"Feng J, Chen Q, Yu F, Wang Z, Chen S, Jin Z, Cai Q, Liu Y, He J (2016) Body mass index and risk of rheumatoid arthritis: a meta-analysis of observational studies. Medicine (Baltimore) 95(8):e2859","journal-title":"Medicine (Baltimore)"},{"key":"4164_CR22","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1007\/s11095-016-2027-9","volume":"33","author":"N Ai","year":"2016","unstructured":"Ai N, Wood RD, Yang E, Welsh WJ (2016) Niclosamide is a negative allosteric modulator of group I metabotropic glutamate receptors: implications for neuropathic pain. Pharm Res 33:3044\u20133056","journal-title":"Pharm Res"},{"key":"4164_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00011-015-0801-5","volume":"64","author":"L Liang","year":"2015","unstructured":"Liang L, Huang M, Xiao Y, Zen S, Lao M, Zou Y, Shi M, Yang X (2015) Xu H. Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflamm Res 64:225\u2013233","journal-title":"Inflamm Res"},{"key":"4164_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7","volume":"43","author":"M Tokuhira","year":"2000","unstructured":"Tokuhira M, Hosaka S, Volin MV, Haines GK 3rd, Katschke KJ Jr, Kim S et al (2000) Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum 43:1122\u20131133","journal-title":"Arthritis Rheum"},{"key":"4164_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/ard.61.9.804","volume":"61","author":"PA Klimiuk","year":"2002","unstructured":"Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J (2002) Soluble adhesion molecules (ICAM-1, VCAM-1 and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 61:804\u2013809","journal-title":"Ann Rheum Dis"},{"key":"4164_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/376517a0","volume":"376","author":"AE Koch","year":"1995","unstructured":"Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517\u2013519","journal-title":"Nature"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4164-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4164-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4164-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T19:14:33Z","timestamp":1559848473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4164-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4164-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"5 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}